Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Live infectious bursal disease virus, strain V877
Zoetis Belgium S.A.
QI01AD09
Live infectious bursal disease virus, strain V877
.
Lyophilisate for use in drinking water
POM: Prescription Only Medicine as defined in relevant national legislation
Chickens
avian infectious bursal disease virus (gumboro disease)
Immunological - Live Vaccine
Authorised
2013-12-09
Health Products Regulatory Authority 11 October 2017 CRN000TZY Page 1 of 5 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Poulvac Bursa Plus Lyophilisate for suspension in drinking water 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Per dose Live Infectious Bursal Disease Virus, strain V877 10 2.2 - 10 3.4 EID 50 * * 50% egg infective dose Excipients For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Lyophilisate for suspension in drinking water. Appearance: brownish tablets. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens, from 10 days of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of chickens with maternal antibody levels of ≤ 500 ELISA units, to reduce mortality and bursal lesions of Gumboro disease. The onset of immunity has been shown by challenge from 14 days after vaccination and the duration of immunity is 32 days. 4.3 CONTRAINDICATIONS Do not vaccinate sick birds. Do not use in infected flocks showing clinical signs. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Use only in flocks with maternal antibody levels of ≤ 500 ELISA units. The optimum day of vaccination is calculated according to the Kouwenhoven’s formula (see section 4.5. Special precautions for use). Due to its residual pathogenicity to the bursae the vaccine should be used only in case of outbreaks of very virulent IBDV strains. Health Products Regulatory Authority 11 October 2017 CRN000TZY Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE I)SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use carefully as Poulvac Bursa Plus spreads from bird to bird and may also spread to nearby flocks. Reversion to virulence studies conducted at the laboratory level demonstrated that there is no increase in virulence after 5 passages in chickens. However, it is recommended to avoid spreading, especially to laying birds. The optimum age for vaccination may be determined with the following method: Determine the ELISA* antibody titres against Gumboro Disease in Les hele dokumentet